Tokyo Tape
Sign in
← Muromachi Chemicals

Quarterly report · Q1

4885.TEDINET S100PCWF
Period2022-06-01 → 2022-08-31
Filed2022-10-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥1.5bn2022-06-01 → 2022-08-31StandaloneNet sales
Revenue¥5.7bn2021-06-01 → 2022-05-31StandaloneNet sales (5-year summary)
Revenue¥1.3bn2021-06-01 → 2021-08-31StandaloneNet sales
Operating income¥130m2022-06-01 → 2022-08-31StandaloneOperating income
Operating income¥169m2021-06-01 → 2021-08-31StandaloneOperating income
Ordinary income¥118m2022-06-01 → 2022-08-31StandaloneOrdinary income
Ordinary income¥423m2021-06-01 → 2022-05-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥170m2021-06-01 → 2021-08-31StandaloneOrdinary income
Profit before tax¥118m2022-06-01 → 2022-08-31StandaloneIncome before income taxes
Profit before tax¥170m2021-06-01 → 2021-08-31StandaloneIncome before income taxes
Net income¥86m2022-06-01 → 2022-08-31StandaloneProfit loss
Net income¥456m2021-06-01 → 2022-05-31StandaloneNet income loss (5-year summary)
Net income¥122m2021-06-01 → 2021-08-31StandaloneProfit loss
Total assets¥4.8bnat 2022-08-31StandaloneAssets
Total assets¥4.8bnat 2022-05-31StandaloneAssets
Total assets¥4.5bnat 2021-08-31StandaloneTotal assets (5-year summary)
Total liabilities¥3.1bnat 2022-08-31StandaloneLiabilities
Total liabilities¥3.1bnat 2022-05-31StandaloneLiabilities
Net assets / equity¥1.7bnat 2022-08-31StandaloneNet assets
Net assets / equity¥1.7bnat 2022-05-31StandaloneNet assets
Net assets / equity¥1.4bnat 2021-08-31StandaloneNet assets (5-year summary)
Cash and deposits¥683mat 2022-08-31StandaloneCash and deposits
Cash and deposits¥865mat 2022-05-31StandaloneCash and deposits
EPS (basic)¥23.132022-06-01 → 2022-08-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥123.792021-06-01 → 2022-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥33.372021-06-01 → 2021-08-31StandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥22.752022-06-01 → 2022-08-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥112.562021-06-01 → 2022-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥30.092021-06-01 → 2021-08-31StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥192021-06-01 → 2022-05-31StandaloneDividend paid per share (5-year summary)
Equity ratio35.7%at 2022-08-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio35.0%at 2022-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio31.0%at 2021-08-31StandaloneEquity to asset ratio (5-year summary)
Shares issued4,095,500at 2022-08-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2022-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2021-08-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segmentrevenue2022-06-01 → 2022-08-31¥508m
jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segmentrevenue external2022-06-01 → 2022-08-31¥508m
jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segmentsegment profit2022-06-01 → 2022-08-31¥26m
jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segmentrevenue2022-06-01 → 2022-08-31¥241m
jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segmentrevenue external2022-06-01 → 2022-08-31¥241m
jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segmentsegment profit2022-06-01 → 2022-08-31−¥711,000
jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segmentrevenue2022-06-01 → 2022-08-31¥778m
jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2022-06-01 → 2022-08-31¥778m
jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2022-06-01 → 2022-08-31¥105m
—segment totalrevenue2022-06-01 → 2022-08-31¥1.5bn
—segment totalrevenue external2022-06-01 → 2022-08-31¥1.5bn
—segment totalsegment profit2022-06-01 → 2022-08-31¥130m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2022-08-31¥1.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2022-08-31¥1.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2022-08-31¥130m
jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segmentrevenue2021-06-01 → 2021-08-31¥469m
jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segmentrevenue external2021-06-01 → 2021-08-31¥469m
jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segmentsegment profit2021-06-01 → 2021-08-31¥19m
jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segmentrevenue2021-06-01 → 2021-08-31¥301m
jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segmentrevenue external2021-06-01 → 2021-08-31¥301m
jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segmentsegment profit2021-06-01 → 2021-08-31¥40m
jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segmentrevenue2021-06-01 → 2021-08-31¥558m
jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2021-06-01 → 2021-08-31¥558m
jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2021-06-01 → 2021-08-31¥111m
—segment totalrevenue2021-06-01 → 2021-08-31¥1.3bn
—segment totalrevenue external2021-06-01 → 2021-08-31¥1.3bn
—segment totalsegment profit2021-06-01 → 2021-08-31¥169m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2021-08-31¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2021-08-31¥1.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2021-08-31¥169m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 363
ItemContextValueUnit
Deposit for subscriptions to treasury stockCurrentQuarterInstant_NonConsolidatedMember223000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember1671415000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember1687160000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember9664000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant_NonConsolidatedMember11599000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember9664000JPY
Valuation and translation adjustmentsCurrentQuarterInstant_NonConsolidatedMember11599000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember1681080000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember1698760000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember4798071000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember4754014000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember1328244000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember1526467000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember842611000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember1068662000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember485633000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember457804000JPY
Salaries and allowances sgaPrior1YTDDuration_NonConsolidatedMember113192000JPY
Salaries and allowances sgaCurrentYTDDuration_NonConsolidatedMember112344000JPY
Legal welfare expenses sgaPrior1YTDDuration_NonConsolidatedMember25148000JPY
Legal welfare expenses sgaCurrentYTDDuration_NonConsolidatedMember25408000JPY
Provision for bonuses sgaPrior1YTDDuration_NonConsolidatedMember25080000JPY
Provision for bonuses sgaCurrentYTDDuration_NonConsolidatedMember25581000JPY
Retirement benefit expenses sgaPrior1YTDDuration_NonConsolidatedMember3553000JPY
Retirement benefit expenses sgaCurrentYTDDuration_NonConsolidatedMember3865000JPY
Share based compensation expenses sgaPrior1YTDDuration_NonConsolidatedMember－JPY
Share based compensation expenses sgaCurrentYTDDuration_NonConsolidatedMember1745000JPY
Provision for directors retirement benefits sgaPrior1YTDDuration_NonConsolidatedMember2960000JPY
Provision for directors retirement benefits sgaCurrentYTDDuration_NonConsolidatedMember－JPY
Other sgaPrior1YTDDuration_NonConsolidatedMember146360000JPY
Other sgaCurrentYTDDuration_NonConsolidatedMember158932000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember316294000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember327877000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember169338000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember129926000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember0JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember9000JPY
Dividends income noiPrior1YTDDuration_NonConsolidatedMember95000JPY
Dividends income noiCurrentYTDDuration_NonConsolidatedMember10000JPY
Foreign exchange gains noiPrior1YTDDuration_NonConsolidatedMember2294000JPY
Foreign exchange gains noiCurrentYTDDuration_NonConsolidatedMember－JPY
Insurance fee income noiPrior1YTDDuration_NonConsolidatedMember1761000JPY
Insurance fee income noiCurrentYTDDuration_NonConsolidatedMember3565000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember1517000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember573000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember5668000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember4158000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember4349000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember4036000JPY
Foreign exchange losses noePrior1YTDDuration_NonConsolidatedMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2022-05-31pass rounding
balance sheet identitynon_consolidated 2022-08-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-05-31pass
statement vs summary · net assetsnon_consolidated 2022-08-31pass
statement vs summary · revenuenon_consolidated 2021-06-01/2021-08-31pass
statement vs summary · revenuenon_consolidated 2022-06-01/2022-08-31pass
statement vs summary · total assetsnon_consolidated 2022-05-31pass
statement vs summary · total assetsnon_consolidated 2022-08-31pass